These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32845937)

  • 1. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
    Manickam C; Sugawara S; Reeves RK
    PLoS Pathog; 2020 Aug; 16(8):e1008820. PubMed ID: 32845937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
    Market M; Angka L; Martel AB; Bastin D; Olanubi O; Tennakoon G; Boucher DM; Ng J; Ardolino M; Auer RC
    Front Immunol; 2020; 11():1512. PubMed ID: 32655581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection-induced immune responses: Friends or foes?
    Li K; Hao Z; Zhao X; Du J; Zhou Y
    Scand J Immunol; 2020 Aug; 92(2):e12895. PubMed ID: 32445403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Dysfunction and Its Role in COVID-19.
    van Eeden C; Khan L; Osman MS; Cohen Tervaert JW
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
    Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID 19: a clue from innate immunity.
    Birra D; Benucci M; Landolfi L; Merchionda A; Loi G; Amato P; Licata G; Quartuccio L; Triggiani M; Moscato P
    Immunol Res; 2020 Jun; 68(3):161-168. PubMed ID: 32524333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin and resistance to SARS coronavirus 2.
    Cunningham L; Simmonds P; Kimber I; Basketter DA; McFadden JP
    J Allergy Clin Immunol; 2020 Jul; 146(1):52-53. PubMed ID: 32422144
    [No Abstract]   [Full Text] [Related]  

  • 11. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
    Jewett A
    Crit Rev Immunol; 2020; 40(2):167-171. PubMed ID: 32749094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2: An immunogenetics call to arms.
    Clark B; Poulton K
    Int J Immunogenet; 2020 Aug; 47(4):319-323. PubMed ID: 32654378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
    Zhang YY; Li BR; Ning BT
    Front Immunol; 2020; 11():2033. PubMed ID: 32922406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
    Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
    J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
    [No Abstract]   [Full Text] [Related]  

  • 16. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term infection of SARS-CoV-2 changed the body's immune status.
    Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
    Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
    Jewett A
    Front Immunol; 2020; 11():1692. PubMed ID: 32754162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
    Hajivalili M; Hosseini M; Haji-Fatahaliha M
    Life Sci; 2020 Sep; 257():118058. PubMed ID: 32653518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.